BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30987719)

  • 1. Glycoproteomic identification of novel plasma biomarkers for oral cancer.
    Chang SC; Lin WL; Chang YF; Lee CT; Wu JS; Hsu PH; Chang CF
    J Food Drug Anal; 2019 Apr; 27(2):483-493. PubMed ID: 30987719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
    Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Fucosylated SERPINA1 as a Novel Plasma Marker for Pancreatic Cancer Using Lectin Affinity Capture Coupled with iTRAQ-Based Quantitative Glycoproteomics.
    Wu CC; Lu YT; Yeh TS; Chan YH; Dash S; Yu JS
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
    Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
    J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies.
    Wong YL; Anand R; Yuen KM; Mustafa WMW; Abraham MT; Tay KK; Rahman ZAA; Chen Y
    Glycoconj J; 2021 Feb; 38(1):1-11. PubMed ID: 33547992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.
    Nie S; Lo A; Wu J; Zhu J; Tan Z; Simeone DM; Anderson MA; Shedden KA; Ruffin MT; Lubman DM
    J Proteome Res; 2014 Apr; 13(4):1873-84. PubMed ID: 24571389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.
    Ahn JM; Sung HJ; Yoon YH; Kim BG; Yang WS; Lee C; Park HM; Kim BJ; Kim BG; Lee SY; An HJ; Cho JY
    Mol Cell Proteomics; 2014 Jan; 13(1):30-48. PubMed ID: 24085812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma.
    Tung CL; Lin ST; Chou HC; Chen YW; Lin HC; Tung CL; Huang KJ; Chen YJ; Lee YR; Chan HL
    J Pharm Biomed Anal; 2013 Mar; 75():7-17. PubMed ID: 23312379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
    Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
    Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel tumor markers for oral squamous cell carcinoma using glycoproteomic analysis.
    Chen YT; Chong YM; Cheng CW; Ho CL; Tsai HW; Kasten FH; Chen YL; Chang CF
    Clin Chim Acta; 2013 May; 420():45-53. PubMed ID: 23078850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis.
    Wu J; Xie X; Nie S; Buckanovich RJ; Lubman DM
    J Proteome Res; 2013 Jul; 12(7):3342-52. PubMed ID: 23731285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
    Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
    Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.
    Zhong ME; Chen Y; Xiao Y; Xu L; Zhang G; Lu J; Qiu H; Ge W; Wu B
    EBioMedicine; 2019 Dec; 50():211-223. PubMed ID: 31753726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and Identification of Pregnancy Zone Protein and Leucine-Rich Alpha-2-Glycoprotein as Potential Serum Biomarkers for Early-Onset Myocardial Infarction using Protein Profile Analysis.
    Xuan C; Li H; Li LL; Tian QW; Wang Q; Zhang BB; Guo JJ; He GW; Lun LM
    Proteomics Clin Appl; 2019 May; 13(3):e1800079. PubMed ID: 30411527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study.
    Wu J; Yin H; Zhu J; Buckanovich RJ; Thorpe JD; Dai J; Urban N; Lubman DM
    PLoS One; 2015; 10(3):e0121112. PubMed ID: 25799488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.
    Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Hernández-Ortíz M; Gallardo-Rincón D; Cantú de León D; Encarnación-Guevara S; Villegas-Pineda JC; Talamás-Rohana P
    J Ovarian Res; 2014 Feb; 7():27. PubMed ID: 24576319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
    Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
    Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
    Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting human serum fucome by an integrated liquid-phase multicolumn platform operating in "cascade" to facilitate comparative mass spectrometric analysis of disease-free and breast cancer sera.
    Selvaraju S; El Rassi Z
    Proteomics; 2013 May; 13(10-11):1701-13. PubMed ID: 23533108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting deeper the human serum fucome by a liquid-phase multicolumn platform in combination with combinatorial peptide ligand libraries.
    Selvaraju S; El Rassi Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():135-42. PubMed ID: 24556279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.